story of the week
Outcomes of Primary SLT vs Eye Drops in Patients With Glaucoma and Ocular Hypertension
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
LiGHT trial: 6-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension
Ophthalmology 2022 Sep 16;[EPub Ahead of Print], G Gazzard, E Konstantakopoulou, D Garway-Heath, M Adeleke, V Vickerstaff, G Ambler, R Hunter, C Bunce, N Nathwani, K BartonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.